Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant adeno-associated virus serotype rhesus 74 expressing the human gamma-sarcoglycan transgene under the control of a myosin heavy chain creatine kinase muscle-specific promoter (rAAVrh74.MHCK7.hSGCG) |
|---|---|
| Date Designated: | 06/25/2025 |
| Orphan Designation: | treatment of limb girdle muscular dystrophy type 2C/R5 |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Sarepta Therapeutics, Inc. 215 First Street Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







